Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Early treatment with low-molecular-weight heparin (LMWH) reduces the risk for death in patients ...

Therapeutic-dose heparin appears to benefit noncritically-ill COVID-19 patients, but it does not reduce deaths or other adverse endpoints compared with usual-care thromboprophylaxis if it’s initiated ...

Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers ...

New research reveals that patients receiving heparin therapy were diagnosed with Alzheimer's disease up to two years later, suggesting a possible protective effect of this common anticoagulant. Study: ...

Taurolidine is an antibacterial and antifungal agent with a mechanism of action that is less prone to development of antimicrobial resistance. A taurolidine/heparin lock solution carries a lower risk ...

Global Heparin Market OverviewThe global heparin market is projected to expand at a steady compound annual growth rate of around 5% through 2031, supported by the rising burden of chronic and ...